ANI Pharmaceuticals Inc (STU:BSFA)
€ 53 -0.5 (-0.93%) Market Cap: 1.13 Bil Enterprise Value: 1.19 Bil PE Ratio: 50.37 PB Ratio: 2.68 GF Score: 86/100

Q3 2022 ANI Pharmaceuticals Inc Earnings Call Transcript

Nov 09, 2022 / 01:00PM GMT
Release Date Price: €37.2 (-0.53%)
Operator

Good morning, everyone. My name is Todd, and I'll be your conference operator. At this time, I'd like to welcome everyone to ANI Pharmaceuticals Third Quarter 2022 Financial Results. (Operator Instructions) As a reminder, this conference call is being recorded today, November 9, 2022.

It is now my pleasure to turn the floor over to Ms. Judy DiClemente, Investor Relations for ANI Pharmaceuticals. Please go ahead.

Judy DiClemente;In;Site Communications;Senior Communications Strategist
Inc.

Thank you, Todd. Welcome to ANI Pharmaceuticals Third Quarter 2022 Earnings Results Call. This is Judy DiClemente of In-Site Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief Financial Officer; and Christopher Mutz, Head of Rare Disease of ANI. You can also access the webcast of this call through the Investors section of the ANI website at www

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot